WDB Holdings Co., Ltd. (2475.T)
Himeji, JP
WDB Holdings Co., Ltd., a Japanese enterprise, primarily delivers human resource solutions, specializing in recruitment and temporary staffing for research and development roles across the biopharmaceutical, chemical, and engineering industries. Beyond staffing, WDB Holdings extends its expertise to offer comprehensive support for the life sciences sector. This encompasses assisting with safety information management, conducting data management and statistical analysis for clinical trials and post-market surveillance, and providing expert consulting along with documentation preparation for product registration. Furthermore, the firm provides clinical trial services, including pharmacovigilance, analytical support, and monitoring. They also contribute to drug discovery through dedicated research and development, alongside custom synthesis services. In addition to these services, WDB Holdings operates a manufacturing division, producing a range of equipment such as gas-assist injection molding machines, nitrogen generators, and various bio-related apparatus. Established in 1985, the company maintains its headquarters in Himeji, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.11% | +17.76% | +14.54% | +11.06% | +11.91% | +7.66% | -4.77% | -16.97% | -28.46% | +99.66% | +1,057.83% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Staffing & Employment Services: +6.7%-1.6% Q1'26: -0.9% (vs Q1'25)
-
EPS growth Staffing & Employment Services: +18.1%-8.8% Q1'26: -35.8% (vs Q1'25)
-
FCF margin FCF growth · Staffing & Employment Services: +32.6%+5.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Staffing & Employment Services: +5.7%+8.9% ★ Q1'26: +7.5% (vs Q1'25)
-
ROIC Staffing & Employment Services: +12.1%+17.2% ★ Q1'26: +13.4% (vs Q1'25)
-
Share dilution Staffing & Employment Services: +0.4%-1.0% ★ Q1'26: -2.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Staffing & Employment Services: -1.18×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
27.65B
est: 27.70B (-0.2%)
|
29.76B
est: 29.85B (-0.3%)
|
32.69B
est: 32.40B (+0.9%)
|
38.00B
est: 38.38B (-1.0%)
|
41.57B
est: 42.60B (-2.4%)
|
43.11B
est: 43.30B (-0.4%)
|
44.13B
est: 43.70B (+1.0%)
|
46.88B
est: 47.00B (-0.3%)
|
47.60B
est: 47.40B (+0.4%)
|
49.30B
est: 50.00B (-1.4%)
|
51.14B
est: 51.50B (-0.7%)
|
50.00B
50.00B – 50.00B
-2.9% YoY
|
51.00B
51.00B – 51.00B
+2.0% YoY
|
52.50B
52.50B – 52.50B
+2.9% YoY
|
| EBITDA |
2.74B
est: 3.36B (-18.6%)
|
2.95B
est: 3.62B (-18.5%)
|
3.51B
est: 3.93B (-10.7%)
|
5.47B
est: 4.66B (+17.3%)
|
5.27B
est: 5.17B (+1.8%)
|
5.29B
est: 5.26B (+0.6%)
|
5.45B
est: 5.31B (+2.7%)
|
6.65B
est: 5.71B (+16.4%)
|
5.78B
est: 5.76B (+0.4%)
|
5.71B
est: 6.07B (-6.0%)
|
5.35B
est: 5.97B (-10.4%)
|
5.79B
5.79B – 5.79B
-2.9% YoY
|
5.91B
5.91B – 5.91B
+2.0% YoY
|
6.08B
6.08B – 6.08B
+2.9% YoY
|
| EBIT |
2.53B
est: 3.19B (-20.7%)
|
2.74B
est: 3.44B (-20.3%)
|
3.30B
est: 3.73B (-11.6%)
|
4.19B
est: 4.42B (-5.2%)
|
4.96B
est: 4.91B (+1.1%)
|
4.96B
est: 4.99B (-0.7%)
|
5.11B
est: 5.04B (+1.5%)
|
6.31B
est: 5.42B (+16.6%)
|
5.51B
est: 5.46B (+0.8%)
|
5.47B
est: 5.76B (-5.1%)
|
5.06B
est: 5.66B (-10.5%)
|
5.49B
5.49B – 5.49B
-2.9% YoY
|
5.60B
5.60B – 5.60B
+2.0% YoY
|
5.77B
5.77B – 5.77B
+2.9% YoY
|
| Net Income |
1.52B
est: 1.32B (+14.8%)
|
1.65B
est: 1.63B (+1.4%)
|
2.07B
est: 1.80B (+15.1%)
|
3.37B
est: 3.21B (+5.2%)
|
2.92B
est: 2.97B (-1.6%)
|
3.11B
est: 3.12B (-0.1%)
|
3.41B
est: 2.69B (+26.8%)
|
4.17B
est: 4.18B (-0.2%)
|
3.54B
est: 3.40B (+4.2%)
|
3.55B
est: 3.55B (-0.1%)
|
3.05B
est: 3.17B (-3.7%)
|
2.64B
2.64B – 2.64B
-16.8% YoY
|
2.89B
2.89B – 2.89B
+9.7% YoY
|
3.09B
3.09B – 3.09B
+7.0% YoY
|
| SGA |
4.06B
est: 3.62B (+12.2%)
|
4.38B
est: 3.90B (+12.4%)
|
4.75B
est: 4.23B (+12.2%)
|
5.02B
est: 5.01B (+0.1%)
|
5.40B
est: 5.56B (-2.9%)
|
6.13B
est: 5.65B (+8.4%)
|
6.12B
est: 5.71B (+7.2%)
|
5.90B
est: 6.14B (-3.8%)
|
6.23B
est: 6.19B (+0.6%)
|
6.26B
est: 6.53B (-4.1%)
|
6.67B
est: 6.75B (-1.2%)
|
6.56B
6.56B – 6.56B
-2.9% YoY
|
6.69B
6.69B – 6.69B
+2.0% YoY
|
6.88B
6.88B – 6.88B
+2.9% YoY
|
| EPS |
75.62
est: 67.30 (+12.4%)
|
82.45
est: 83.05 (-0.7%)
|
103.37
est: 91.70 (+12.7%)
|
168.73
est: 163.28 (+3.3%)
|
147.31
est: 151.20 (-2.6%)
|
156.97
est: 158.80 (-1.2%)
|
171.79
est: 136.80 (+25.6%)
|
211.32
est: 212.80 (-0.7%)
|
179.75
est: 173.10 (+3.8%)
|
180.67
est: 180.80 (-0.1%)
|
155.36
est: 162.90 (-4.6%)
|
135.50
135.50 – 135.50
-16.8% YoY
|
148.60
148.60 – 148.60
+9.7% YoY
|
159.00
159.00 – 159.00
+7.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-14 | S- | 5/5 | 5/5 | 4/5 | 5/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-13 | S- | 5/5 | 5/5 | 4/5 | 5/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-12 | S- | 5/5 | 5/5 | 4/5 | 5/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-11 | A+ | 5/5 | 5/5 | 3/5 | 5/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-08 | A+ | 5/5 | 5/5 | 3/5 | 5/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-07 | A+ | 5/5 | 5/5 | 3/5 | 5/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-01 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-30 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-28 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-27 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | T. Rowe Price International Equity Research ETF TIER | 0.06% | 20.7K | 0.38% |
| 2 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 83.1K | 0.40% |
| 3 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 28.1K | 0.45% |
| 4 | Dimensional - International Small Cap ETF DFIS | 0.00% | 204.2K | 0.39% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 357.9K | 0.06% |
| 6 | iShares Core TOPIX ETF 1475.T | 0.00% | 229.4K | 0.05% |
| 7 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 125.9K | 0.22% |
| 8 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 1.2K | 0.22% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 38.8K | 0.28% |
| 10 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 1.6K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Masahisa Kato | MD & Director | — | — |
| Miki Otsuka | Senior MD & Director | — | female |
| Toshimitsu Nakano | Chief Executive Officer, President & Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2475.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
